Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance study of ONO-2020 in Japanese healthy adult males
jRCT2071250125Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ONO-2020, sponsored by Ono Pharmaceutical. Primary endpoints: Urinary excretion rate of radioactivity, Fecal excretion rate of radioactivity and 1 more. Started Feb 2026; status: completed.
02
Drugs
ONO-2020
Beyond the preview
Go deeper on jRCT2071250125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250125.